Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Human interferon beta gene therapy with selective activity against RCC

Nov. 13, 2002

Cannabis-based medicine advances to phase II trials in patients undergoing chemotherapy

Nov. 13, 2002

Urokinase inhibitors with utility in cancer covered by Pentapharm patent

Nov. 13, 2002

Taisho claims preparation and use of two series of VEGF antagonists

Nov. 13, 2002

FDA designates Orathecin as a fast track drug

Nov. 12, 2002

ENMD-0995 receives orphan drug designation

Nov. 12, 2002

Antitumor activity of TRAIL-R1 MAb demonstrated in vitro and in vivo

Nov. 12, 2002

New antitumor hydroxamates prepared and tested at Ono

Nov. 12, 2002

Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy

Nov. 12, 2002

Cyclis licenses broad technology to expand ACT platform

Nov. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...